Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide

Journal of Molecular Biology

Volumn 297, Issue 1, 2000, Pages 73-87

  Huang, T H Jackson ^a   Yang, Dun Sheng ^c   Plaskos, Nicholas P ^b   Go, Sandy ^a   Yip, Christopher M ^b   Fraser, Paul E ^a,c   Chakrabartty, Avijit ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Amyloid; Fibril; Protein structure; Protofibril

Indexed keywords

AMYLOID BETA PROTEIN; OLIGOMER;

ALPHA HELIX; ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM; ENERGY TRANSFER; FIBER; HUMAN; MOLECULAR WEIGHT; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE;

EID: 0034677660     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3559     Document Type: Article

References (46)

1. Solution conformations and aggregational properties of synthetic b-peptides of Alzheimer's disease. Analysis of circular dichroism spectra
2. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo
3. The pathology of the neuronal cytoskeleton in Alzheimer's disease
4. Molecular modelling of the Abeta1-42 peptide from Alzheimer's disease
5. Spectroscopic studies on Invertebrate myosins and light chains
6. The effect of enhanced alpha-helicity on the activity of a winter flounder antifreeze polypeptide
7. Contribution of aromatic side-chains to far ultraviolet circular dichroism of helical peptides and its effect on measurement of helix propensities
8. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
9. Spectroscopic determination of tryptophan and tyrosine in proteins
10. Fibril formation by primate, rodent, and Dutch-hemorrahagic analogues of Alzheimer amyloid β-protein
11. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
12. Soluble amyloid Abeta(1-40) exists as a stable dimer at low concentrations
13. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
14. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
15. Assembly of Abeta amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease
16. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease bA4 peptides
17. Fibrillogenesis of Alzheimer beta-amyloid peptides studied by fluorescence energy transfer
18. Synthesis and characterization of two fluorescent sulfhydryl reagents
19. Analysis of data from the analytical ultracentrifuge by nonlinear least squares techniques
20. In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: New insights into mechanism of beta-sheet formation
21. Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains
22. Temperature dependence of amyloid beta-protein fibrillization
23. Diffusible nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins
24. Thioflavine T interaction with synthetic Alzheimer's disease b-amyloid peptides: Detection of amyloid aggregation in solution
25. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
26. Solvent content of protein crystals
27. Unusually stable helix formation in short alanine-based peptides
28. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
29. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state
30. Morphology and toxicity of Abeta(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
31. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fibril morphology
32. The molecular pathology of Alzheimer's disease
33. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro
34. Amyloid-beta aggregation: Selective inhibition of aggregation in mixtures with different chain lengths
35. Surfactant properties of Alzheimer Abeta peptides and the mechanism of amyloid aggregation
36. Boundary analysis in sedimentation transport experiments: A procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile
37. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy
38. Presence of soluble amyloid-beta peptide precedes amyloid plaque formation in Down's syndrome
39. Neuropathological changes in Alzheimer disease
40. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
41. Rotary shadowing of extended molecules dried from glycerol
42. Amyloid betaprotein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
43. Physical, morphological, and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ
44. Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain